Vimarsana
Biggest News Aggregation in the World

Page 4 - Clinical Validation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Validation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Validation Today - Breaking & Trending Today

Optical Biometer Developed for Myopia Control in Children - Vimarsana News

Optical Biometer Developed for Myopia Control in Children

The Myah device, a new optical biometer, underwent clinical validation in research published in the journal Children. The study examined its consistency in biometric measurements and agreement with the widely available optical biometer, Myopia Master.

Karolinska Institutet researchers win over €9M in Horizon funding - Vimarsana News

Karolinska Institutet researchers win over €9M in Horizon funding

Through the Horizon Europe programme, researchers at Karolinska Institutet have been granted large financial grants for approximately 20 different projects aimed at solving various societal challenges in health. One of the projects will explore the possibility of creating a common system for the reuse of already approved medicines to treat various diseases.

Digital Medicine Society (DiMe): Digital Health Leaders Align on Nocturnal Scratch as a Digital Endpoint for Atopic Dermatitis - Vimarsana News

Digital Medicine Society (DiMe): Digital Health Leaders Align on Nocturnal Scratch as a Digital Endpoint for Atopic Dermatitis

BOSTON, Sept. 8, 2022 /PRNewswire/ -- The Digital Medicine Society (DiMe) has released a new set of resources to advance the use of digitally measured nocturnal scratch as a meaningful endpoint

Myriad Genetics, Inc.: New Study Published in Clinical Cancer Research Journal Highlights Use of EndoPredict Test to Inform Treatment for Premenopausal Breast Cancer Patients - Vimarsana News

Myriad Genetics, Inc.: New Study Published in Clinical Cancer Research Journal Highlights Use of EndoPredict Test to Inform Treatment for Premenopausal Breast Cancer Patients

Myriad Genetics' EndoPredict test accurately identified premenopausal women with ER+, HER2- breast cancer who could safely avoid adjuvant chemotherapy SALT LAKE CITY, Aug. 31, 2022 1 that shows the

Digital Biomarkers Drug Development Market Report 2022: Transformational Growth for Clinical Trials via Enhancements to Patient Recruitment, Stratification, Monitoring, and Drug Response Comprehension - Vimarsana News

Digital Biomarkers Drug Development Market Report 2022: Transformational Growth for Clinical Trials via Enhancements to Patient Recruitment, Stratification, Monitoring, and Drug Response Comprehension

/PRNewswire/ -- The "Growth Opportunities for Digital Biomarkers in Drug Development" report has been added to ResearchAndMarkets.com's offering. The study...